Delivery Order SPE2DB24D2012-SPE2DB25FBWDT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed-price, non-set-aside contract was awarded competitively and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a $4.69K delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors, with completion targeted for October 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tezspire is a biologic respiratory treatment used for moderate-to-severe...
- The Defense Logistics Agency awarded a $7,409.34 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors on November 13, 2025, with completion expected by December 5, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a single transaction under AmerisourceBergen's larger pharmaceutical supply relationship with DLA. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors on July 31, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by August 21, 2025, with performance taking place at the vendor's corporate headquarters in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order valued at $7,030.77 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Tezspire 210 mg/1.91 mL pen auto-injectors. The contract is non-competitive, firm fixed price delivery order with an ultimate completion date of September 8, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Tezspire 210 mg/1.91 ml pen auto-injectors. This firm fixed-price delivery order, valued at $4,687.18, carries an ultimate completion date of August 21, 2025, and represents a non-competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $11,717.95 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on September 25, 2025, with an ultimate completion date of October 17, 2025. This firm fixed price, competitively awarded contract—placed with no set-aside designation—represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a $11,717.95 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors. This firm fixed-price, competitively awarded contract has an ultimate completion date of September 10, 2025, and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Tezspire is a biologic medication used to treat moderate-to-severe asthma, representing the type of specialized pharmaceutical product critical to military...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors, with an ultimate completion date of September 3, 2025. This is a non-set-aside competitive award issued on August 12, 2025, with performance conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $2,343.59 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors, with an ultimate completion date of October 9, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is issued under...
- SPE2DB24D2012Indefinite Delivery Contract
- SPE2DB24D2012-SPE2DB25FBWDTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,687.18 to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 ml pen auto-injectors on June 9, 2025, with a completion date of July 1, 2025. This firm fixed-price, non-set-aside delivery order represents a competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania. Tezspire is a specialty biologic medication used for severe asthma management, reflecting the breadth of pharmaceutical commodities supplied by AmerisourceBergen through its DLA contracts. As a major pharmaceutical distributor headquartered in Pennsylvania, the company fulfills critical medical supply needs for military healthcare systems, the Defense Health Agency, and other federal medical programs. This delivery order exemplifies the ongoing operational support provided under the larger IDC vehicle, which enables flexible procurement of brand-name medications, generics, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 6/9/25 |